IGM Biosciences filed the paperwork for its IPO on 8/19/19. The company will raise up to $100 Million. IGM is pioneering the development of engineered IgM antibodies for cancer treatments. The company will trade on NASDAQ under the symbol "IGMS."
Do Not Allow Advertisers to Use My Personal information
Copyright © 2020,